Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus
- PMID: 11585369
- DOI: 10.4158/EP.7.5.346
Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus
Abstract
Objective: To study bone mineral density (BMD) and bone remodeling factors at the time of diagnosis of adult-onset type 1 diabetes mellitus (DM).
Methods: In 22 men and 10 women, who ranged in age from 20 to 39 years, a study was undertaken promptly after diagnosis of type 1 DM (on the basis of criteria established by the World Health Organization). Before any treatment, the clinical history, glycemia, ketonuria, basal and glucagon-stimulated C-peptide levels, islet cell antibodies (ICA), glutamic acid decarboxylase autoantibodies (GADA), and bone remodeling variables were recorded for all the study subjects. Dual-energy x-ray absorptiometry (Hologic QDR1000) was performed to measure BMD in the lumbar spine (LS), femoral neck (FN), and Ward's triangle.
Results: Of the 32 patients, 24 (75%) showed positive levels of ICA or GADA (or both), whereas 8 (25%) tested negative. The BMD values-Z-scores (standard deviation [SD] adjusted for age and sex)-were lower among the patients with DM than in a matched healthy population in both the LS (-0.61 +/- 1.23 SD; P = 0.008) and the FN (-0.38 +/- 1.00 SD; P = 0.003). Twelve patients had a T-score between -2.5 SD and -1 SD in the LS, and 14 had the same scores in the FN and were classified as having osteopenia. A correlation was found between BMD values and C-peptide levels in the LS (r = 0.231; P = 0.02) and the FN (r = 0.27; P = 0.01). The BMD values did not correlate with bone remodeling markers, hemoglobin A1c, or immunologic variables.
Conclusion: We found reduced bone mass in patients with type 1 DM at the time of the clinical diagnosis. A high percentage of patients with DM have osteopenia, which may not, therefore, be a late complication of type 1 DM. These findings need to be confirmed in larger studies.
Similar articles
-
Bone mineral density of both genders in Type 1 diabetes according to bone composition.J Diabetes Complications. 2006 Sep-Oct;20(5):302-7. doi: 10.1016/j.jdiacomp.2005.07.006. J Diabetes Complications. 2006. PMID: 16949517
-
Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.Calcif Tissue Int. 1999 Jul;65(1):23-8. doi: 10.1007/s002239900652. Calcif Tissue Int. 1999. PMID: 10369729
-
Differences in prevalence of reduced and low bone mineral density between lumbar spine and femoral neck in peritoneal dialysis patients using dual-energy X-ray absorptiometry (DXA).Perit Dial Int. 2023 Jul;43(4):334-338. doi: 10.1177/08968608221146867. Epub 2023 Jan 10. Perit Dial Int. 2023. PMID: 36627766
-
Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature.Osteoporos Int. 2017 Sep;28(9):2601-2610. doi: 10.1007/s00198-017-4097-x. Epub 2017 Jun 3. Osteoporos Int. 2017. PMID: 28580510 Review.
-
High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.Clin Rheumatol. 2012 Nov;31(11):1529-35. doi: 10.1007/s10067-012-2018-0. Epub 2012 Jun 16. Clin Rheumatol. 2012. PMID: 22706444 Free PMC article. Review.
Cited by
-
Type I diabetic bone phenotype is location but not gender dependent.Histochem Cell Biol. 2007 Aug;128(2):125-33. doi: 10.1007/s00418-007-0308-4. Epub 2007 Jul 3. Histochem Cell Biol. 2007. PMID: 17609971
-
Evaluation of bone mineral status in prepuberal children with newly diagnosed type 1 diabetes.Ann Pediatr Endocrinol Metab. 2018 Sep;23(3):136-140. doi: 10.6065/apem.2018.23.3.136. Epub 2018 Sep 28. Ann Pediatr Endocrinol Metab. 2018. PMID: 30286569 Free PMC article.
-
Increase in Bone Mass Before Onset of Type 1 Diabetes Mellitus in Rats.In Vivo. 2022 May-Jun;36(3):1077-1082. doi: 10.21873/invivo.12805. In Vivo. 2022. PMID: 35478116 Free PMC article.
-
Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women.Osteoporos Int. 2012 Apr;23(4):1235-43. doi: 10.1007/s00198-011-1675-1. Epub 2011 Jun 10. Osteoporos Int. 2012. PMID: 21660558
-
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes.J Endocrinol Invest. 2017 Oct;40(10):1091-1098. doi: 10.1007/s40618-017-0672-4. Epub 2017 Apr 11. J Endocrinol Invest. 2017. PMID: 28401528
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous